Dermatology Conference Coverage
This content was developed independently and is not endorsed by the American Academy of Dermatology.
Atopic Dermatitis Treatment is a Good News Story, Say Symposium Panelists | AMCP 2022
March 30th 2022Dupixent (dupilumab) ushered in a new era and a growing number of treatment options has brought awareness to the condition. But the panelists also discussed problems with step therapy, delays and denials of treatment and the lack of a “gold standard” test for diagnosis.
Read More
